D.E. Shaw & Co
LUNG icon

D.E. Shaw & Co’s Pulmonx LUNG Stock Holding History

D.E. Shaw & Co’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426K Sell
327,528
-7,546
-2% -$10.4K ﹤0.01% 4260
2026
Q1 		$432K Sell
335,074
-226,192
-40% -$374K ﹤0.01% 3924
2025
Q4 		$1.24M Sell
561,266
-227,983
-29% -$429K ﹤0.01% 3392
2025
Q3 		$1.28M Buy
789,249
+299,369
+61% +$626K ﹤0.01% 3299
2025
Q2 		$1.27M Buy
489,880
+3,325
+0.7% +$13.1K ﹤0.01% 3068
2025
Q1 		$3.27M Buy
486,555
+93,719
+24% +$664K ﹤0.01% 2222
2024
Q4 		$2.67M Buy
392,836
+32,049
+9% +$211K ﹤0.01% 2503
2024
Q3 		$2.99M Sell
360,787
-18,231
-5% -$132K ﹤0.01% 2379
2024
Q2 		$2.4M Sell
379,018
-52,279
-12% -$402K ﹤0.01% 2493
2024
Q1 		$4M Sell
431,297
-191,291
-31% -$2.24M ﹤0.01% 2064
2023
Q4 		$7.94M Sell
622,588
-45,770
-7% -$477K 0.01% 1547
2023
Q3 		$6.9M Sell
668,358
-48,020
-7% -$556K 0.01% 1551
2023
Q2 		$9.39M Buy
716,378
+142,214
+25% +$1.74M 0.01% 1390
2023
Q1 		$6.42M Buy
574,164
+320,174
+126% +$3.16M 0.01% 1734
2022
Q4 		$2.14M Buy
+253,990
New +$2.42M ﹤0.01% 2889
2021
Q2 		– Sell
-23,636
Closed -$1.08M – 4898
2021
Q1 		$1.08M Buy
+23,636
New +$1.36M ﹤0.01% 3053

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

D.E. Shaw & Co's LUNG Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Pulmonx (LUNG) stake by 2.3% in Q2 2026, selling an estimated $10.4K and leaving 327,528 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #4260.

D.E. Shaw & Co first reported a position in LUNG in Q1 2021 and has held it in 16 quarters since. The position peaked at $9.39M in Q2 2023. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • D.E. Shaw & Co held 327,528 shares of Pulmonx worth $426K as of Q2 2026.
  • D.E. Shaw & Co sold 7,546 Pulmonx shares in Q2 2026, an estimated $10.4K.
  • Pulmonx made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4260 holding.
  • D.E. Shaw & Co first reported a position in Pulmonx in Q1 2021 and has held it in 16 quarters since.
  • D.E. Shaw & Co's Pulmonx position peaked at $9.39M in Q2 2023.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.